Impact of HCQ on SLE occurrence. Patients with SLE (A) and SLE free survival (B) for patients with positive antinuclear antibody (patients with ANA) without a concomitant diagnosis of SLE at AIC diagnosis (n = 322) according to the previous use of HCQ for AIC.